UBS lowered the firm’s price target on EQT Corporation (EQT) to $54 from $55 and keeps a Neutral rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EQT:
- EQT Corporation price target lowered to $62 from $67 at Morgan Stanley
- EQT Corporation price target lowered to $57 from $59 at Stephens
- EQT Corporation price target raised to $57 from $54 at Scotiabank
- EQT Corporation to sell Karo Healthcare to KKR, terms undisclosed
- EQT Corporation upgraded to Buy from Hold at TD Cowen